Table 2.
Univariate and multivariate analyses of OS for the 156 CRC patients
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| P | HR | 95% CI | P | HR | 95% CI | |
| Ages (<64 / ≥64) | 0.071 | 1.567 | 0.962–2.551 | |||
| Gender (male/female) | 0.404 | 0.815 | 0.505–1.317 | |||
| Tumor size (<5 cm / ≥5 cm) | 0.817 | 0.945 | 0.585–1.527 | |||
| Nodal status (negative/positive) | 0.000 | 2.823 | 1.689–4.719 | 0.050 | 0.299 | 0.089–1.002 |
| Differentiation (well or moderately/poorly) | 0.000 | 3.358 | 2.004–5.625 | 0.002 | 2.442 | 1.393–4.281 |
| Tumor stage (I + II/ III + IV) | 0.000 | 3.342 | 1.956–5.711 | 0.001 | 7.529 | 2.167–26.156 |
| srGAP1 expression (low/ high) | 0.006 | 0.487 | 0.290–0.817 | 0.070 | 0.613 | 0.360–1.041 |
HR hazard ration, 95%, CI 95% confidence interval